Kohei Somekawa

Adverse events induced by nivolumab and ipilimumab combination regimens

Kohei Somekawa, Nobuyuki Horita, Ayami Kaneko et al. · Therapeutic Advances in Medical Oncology · 2022 · 25 citations · Full text

Pharmacy, Oncology, Pharmacology +16

Aetiological agents of adult community-acquired pneumonia in Japan: systematic review and meta-analysis of published data

Yuji Fujikura, Kohei Somekawa, Toshie Manabe et al. · BMJ Open Respiratory Research · 2023 · 18 citations · Full text

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +14

Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor

Sousuke Kubo, Nobuaki Kobayashi, Kohei Somekawa et al. · Anticancer Research · 2020 · 17 citations · Full text

Medicine, Immunology, Oncology +17

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial

Hiromi Matsumoto, Nobuaki Kobayashi, Kohei Somekawa et al. · Thoracic Cancer · 2021 · 16 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer

Chisato Kamimaki, Nobuaki Kobayashi, Momo Hirata et al. · Thoracic Cancer · 2021 · 11 citations · Full text

Life Sciences, Immunology, Oncology +17